Speaker: Christian Chabannon

0:01:21

2nd European CAR T-Cell Meeting: Christian Chabannon's highlights

0:02:17

Improving access to advanced therapies: the access to CAR-T in Europe

0:01:53

Preclinical research for the future of cellular therapies

0:02:10

Optimizing CAR-T therapy in LBCL

0:02:03

An update on the latest developments in the field of CAR-T therapy

0:01:06

CAR-T cell therapy: current applications and how to improve treatment strategies in the future

0:54:24

How to ensure unrelated donor grafts & CAR-T cell products during the Corona pandemic

0:01:03

LentiGlobin BB305 for β-Thalassemia

0:01:15

The current status of CAR-T therapy in second-line DLBCL in Europe

0:01:54

The benefits of using plerixafor in mobilization treatment

0:01:33

The importance of addressing inequalities in access to CAR-T therapy & the role of the MDT

0:01:54

Work of the WBMT to improve access to advanced cancer therapies

0:01:41

The consequences of regulatory changes on access to devices and reagents needed for graft processing

0:02:21

Practical considerations for DLI after haploidentical SCT

0:00:37

Hot topics in CAR T-cell therapy for ALL

0:01:20

Overview of the Cellular Therapy & Immunobiology Working Party

0:02:42

The benefits of the European CAR T-cell Meeting to young investigators

0:02:25

EBMT session highlights: latest advances in cell therapy

0:01:33

Addressing the changing needs for ad-hoc resources for safe delivery of advanced therapies

0:01:23

Cellular therapy news coming up at the 2020 EBMT Annual Meeting

0:01:27

A historical transition in cancer therapy

0:02:03

Pharmacoeconomics of mobilization

0:02:26

The future directions of EBMT: introduction of cellular and gene therapy

0:01:37

Key topics at the EBMT International Transplant Course 2016